UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Group by: Author | Type
Jump to: B | C | D | E | G | H | J | K | L | M | N | O | P | R | S | T | U | W
Number of items: 55.

B

Barrington, SF; Phillips, EH; Counsell, N; Hancock, B; Pettengell, R; Johnson, P; Townsend, W; ... Radford, J; + view all (2019) Positron Emission Tomography Score Has Greater Prognostic Significance Than Pretreatment Risk Stratification in Early-Stage Hodgkin Lymphoma in the UK RAPID Study. Journal of Clinical Oncology , 37 (20) pp. 1732-1741. 10.1200/JCO.18.01799. Green open access
file

Barrington, SF; Phillips, EH; Counsell, N; Radford, J; (2019) Reply to H.J.A. Adams et al and C. Kobe et al. Journal of Clinical Oncology , 37 (34) pp. 3325-3326. 10.1200/JCO.19.02056. Green open access
file

Barton, J; Pacey, K; Jain, N; Kasia, T; Edwards, D; Thevanesan, C; Straathof, K; ... Anderson, J; + view all (2019) Establishment and phenotyping of neurosphere cultures from primary neuroblastoma samples. F1000Research , 8 , Article 823. 10.12688/f1000research.18209.1. Green open access
file

Biswas, D; Birkbak, NJ; Rosenthal, R; Hiley, CT; Lim, EL; Papp, K; Boeing, S; ... TRACERx Consortium; + view all (2019) A clonal expression biomarker associates with lung cancer mortality. Nature Medicine , 25 pp. 1540-1548. 10.1038/s41591-019-0595-z. Green open access
file

Bray, TJP; Lopes, A; Fisher, C; Ciurtin, C; Sen, D; Hall-Craggs, MA; (2019) Sacroiliac Joint Ankylosis In Young Spondyloarthritis Patients Receiving Biologic Therapy: Observation of Serial MRI scans. Arthritis and Rheumatology , 71 (4) pp. 594-598. 10.1002/art.40750. Green open access
file

Brown, P; Tan, A-C; El-Esawi, MA; Liehr, T; Blanck, O; Gladue, DP; Almeida, GMF; ... Shalchyan, V; + view all (2019) Large expert-curated database for benchmarking document similarity detection in biomedical literature search. Database pp. 1-66. 10.1093/database/baz085. Green open access
file

Burt, R; Dey, A; Aref, S; Aguiar, M; Akarca, A; Bailey, K; Day, W; ... Fielding, AK; + view all (2019) Activated stromal cells transfer mitochondria to rescue acute lymphoblastic leukemia cells from oxidative stress. Blood , 134 (17) pp. 1415-1429. 10.1182/blood.2019001398. Green open access
filefile

C

Chavda, SJ; Maciocia, PM; Mesiri, P; Counsell, N; Kothari, J; Bird, A; Mariner, C; ... Yong, K; + view all (2019) A new prognostic model for myeloma patients relapsing from upfront autologous transplantation based on ISS and PFS1. British Journal of Haematology , 185 (2) pp. 350-353. 10.1111/bjh.15487. Green open access
file

Chemi, F; Rothwell, DG; McGranahan, N; Gulati, S; Abbosh, C; Pearce, SP; Zhou, C; ... TRACERx Consortium, .; + view all (2019) Pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapse. Nature Medicine , 25 pp. 1534-1539. 10.1038/s41591-019-0593-1. Green open access
file

Clamp, AR; James, EC; McNeish, IA; Dean, A; Kim, J-W; O'Donnell, DM; Hook, J; ... Ledermann, JA; + view all (2019) Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial. The Lancet 10.1016/s0140-6736(19)32259-7. Green open access
filefile

Cohen, OC; Counsell, N; Rabin, N; Popat, R; Owen, RG; Popova, B; Schofield, O; ... Yong, KL; + view all (2019) Bortezomib consolidation post-ASCT as frontline therapy for multiple myeloma deepens disease response and MRD-negative rate whilst maintaining QOL and response to re-treatment at relapse. [Letter]. British Journal of Haematology , 185 (5) pp. 948-951. 10.1111/bjh.15649. Green open access
file

Coleman, RL; Ledermann, JA; (2019) Maintenance treatment for recurrent ovarian carcinoma – Evidence supporting the efficacy and safety of PARP inhibitors. [Review]. European Oncology and Haematology , 15 (1) pp. 29-40. 10.17925/EOH.2019.15.1.29. Green open access
file

Colombo, N; Sessa, C; du Bois, A; Ledermann, J; McCluggage, WG; McNeish, I; Morice, P; ... Zeimet, AG; + view all (2019) ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease. International Journal of Gynecological Cancer , 29 (4) pp. 728-760. 10.1136/ijgc-2019-000308. Green open access
file

Colombo, N; Sessa, C; du Bois, A; Ledermann, J; McCluggage, WG; McNeish, I; Morice, P; ... ESMO–ESGO Ovarian Cancer Consensus Conference Working Group, .; + view all (2019) ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease. Annals of Oncology , 30 (5) pp. 672-705. 10.1093/annonc/mdz062. Green open access
file

Coosemans, A; Vankerckhoven, A; Baert, T; Boon, L; Ruts, H; Riva, M; Blagden, S; ... Vergote, I; + view all (2019) Combining conventional therapy with immunotherapy: A risky business? European Journal of Cancer , 113 pp. 41-44. 10.1016/j.ejca.2019.02.014. Green open access
filefile

D

Das-Gupta, E; Thomson, KJ; Bloor, AJC; Clark, AD; Mackinnon, S; Kayani, I; Clifton-Hadley, L; ... Peggs, KS; + view all (2019) Allo-HSCT in transplant-naive patients with Hodgkin lymphoma: a single-arm, multicenter study. Blood Advances , 3 (24) pp. 4264-4270. 10.1182/bloodadvances.2019001016. Green open access
file

de Boer, SM; Powell, ME; Mileshkin, L; Katsaros, D; Bessette, P; Haie-Meder, C; Ottevanger, PB; ... Tubiana-Mathieu, N; + view all (2019) Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial. The Lancet Oncology 10.1016/S1470-2045(19)30395-X. (In press). Green open access
file

Dehbi, H-M; Mallick, U; Wadsley, J; Newbold, K; Harmer, C; Hackshaw, A; (2019) Recurrence after low-dose radioiodine ablation and recombinant human thyroid-stimulating hormone for differentiated thyroid cancer (HiLo): long-term results of an open-label, non-inferiority randomised controlled trial. Lancet Diabetes and Endocrinology , 7 (1) pp. 44-51. 10.1016/S2213-8587(18)30306-1. Green open access
file

E

Embleton-Thirsk, A; Deane, E; Townsend, S; Farrelly, L; Popoola, B; Parker, J; Rustin, G; ... Kaplan, R; + view all (2019) Impact of retrospective data verification to prepare the ICON6 trial for use in a marketing authorization application. Clinical Trials , 16 (5) pp. 502-511. 10.1177/1740774519862528. Green open access
file

Eyre, TA; Kirkwood, AA; Gohill, S; Follows, G; Walewska, R; Walter, H; Cross, M; ... the UK CLL Forum; + view all (2019) Efficacy of venetoclax monotherapy in patients with relapsed chronic lymphocytic leukaemia in the post-BCR inhibitor setting: a UK wide analysis. British Journal of Haematology , 185 (4) pp. 656-669. 10.1111/bjh.15802. Green open access
file

Eyre, TA; Kirkwood, AA; Wolf, J; Hildyard, C; Mercer, C; Plaschkes, H; Griffith, J; ... Hatton, CSR; + view all (2019) Stand-alone intrathecal central nervous system (CNS) prophylaxis provide unclear benefit in reducing CNS relapse risk in elderly DLBCL patients treated with R-CHOP and is associated increased infection-related toxicity. British Journal of Haematology , 187 (2) pp. 185-194. 10.1111/bjh.16070. Green open access
filefilefilefilefilefile

G

Ghorashian, S; Kramer, AM; Onuoha, S; Wright, G; Bartram, J; Richardson, R; Albon, SJ; ... Amrolia, PJ; + view all (2019) Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL treated with a low-affinity CD19 CAR. Nature Medicine , 25 pp. 1408-1414. 10.1038/s41591-019-0549-5. Green open access
file

González Martín, A; Oza, A; Embleton, AC; Pfisterer, J; Ledermann, J; Pujade-Lauraine, E; Kristensen, G; ... Perren, T; + view all (2019) Exploratory outcome analyses according to stage and/or residual disease in the ICON7 trial of carboplatin and paclitaxel with or without bevacizumab for newly diagnosed ovarian cancer. Gynecologic Oncology , 152 (1) 10.1016/j.ygyno.2018.08.036. Green open access
file

Gore, M; Hackshaw, A; Brady, WE; Penson, RT; Zaino, R; McCluggage, WG; Ganesan, R; ... Gershenson, DM; + view all (2019) An international, phase III randomized trial in patients with mucinous epithelial ovarian cancer (mEOC/GOG 0241) with long-term follow-up: and experience of conducting a clinical trial in a rare gynecological tumor. Gynecologic Oncology , 153 (3) pp. 541-548. 10.1016/j.ygyno.2019.03.256. Green open access
file

Gourley, C; Balmaña, J; Ledermann, JA; Serra, V; Dent, R; Loibl, S; Pujade-Lauraine, E; (2019) Moving From Poly (ADP-Ribose) Polymerase Inhibition to Targeting DNA Repair and DNA Damage Response in Cancer Therapy. Journal of Clinical Oncology , 37 (25) pp. 2257-2269. 10.1200/JCO.18.02050. Green open access
file

H

Hainsworth, Emma Georgina; (2019) HIV positive and treated for cancer: the social context and lived experiences of dual diagnosis and its treatment. Doctoral thesis (Ph.D), UCL (University College London). Green open access
file

Hoskin, PJ; Hopkins, K; Misra, V; Holt, T; McMenemin, R; Dubois, D; McKinna, F; ... Lopes, A; + view all (2019) Effect of Single-Fraction vs Multifraction Radiotherapy on Ambulatory Status Among Patients With Spinal Canal Compression From Metastatic Cancer: The SCORAD Randomized Clinical Trial. JAMA , 322 (21) pp. 2084-2094. 10.1001/jama.2019.17913.

Hutchison, IL; Ridout, F; Cheung, SMY; Shah, N; Hardee, P; Surwald, C; Thiruchelvam, J; ... Hackshaw, A; + view all (2019) Nationwide randomised trial evaluating elective neck dissection for early stage oral cancer (SEND study) with meta-analysis and concurrent real-world cohort. British Journal of Cancer 10.1038/s41416-019-0587-2. (In press). Green open access
file

J

Joshi, K; Robert de Massy, M; Ismail, M; Reading, JL; Uddin, I; Woolston, A; Hatipoglu, E; ... Chain, B; + view all (2019) Spatial heterogeneity of the T cell receptor repertoire reflects the mutational landscape in lung cancer. Nature Medicine , 25 pp. 1549-1559. 10.1038/s41591-019-0592-2. Green open access
file

K

Kristeleit, RS; Oaknin, A; Ray-Coquard, I; Leary, A; Balmaña, J; Drew, Y; Oza, AM; ... McNeish, IA; + view all (2019) Antitumor activity of the poly(ADP-ribose) polymerase inhibitor rucaparib as monotherapy in patients with platinum-sensitive, relapsed, BRCA-mutated, high-grade ovarian cancer, and an update on safety. International Journal of Gynecological Cancer , 29 (9) pp. 1396-1404. 10.1136/ijgc-2019-000623. Green open access
file

L

Latifoltojar, A; Punwani, S; Lopes, A; Humphries, PD; Klusmann, M; Menezes, LJ; Daw, S; ... Taylor, SA; + view all (2019) Whole-body MRI for staging and interim response monitoring in paediatric and adolescent Hodgkin's lymphoma: a comparison with multi-modality reference standard including 18F-FDG-PET-CT. European Radiology , 29 (1) pp. 202-212. 10.1007/s00330-018-5445-8. Green open access
filefile

Ledermann, JA; (2019) Do increased tumor infiltrating lymphocytes co-existing with Homologous Recombination Deficiency provide clues to enhance immunotherapy of ovarian cancer? [Editorial comment]. Gynecologic Oncology , 153 (2) pp. 213-214. 10.1016/j.ygyno.2019.04.014. Green open access
file

Ledermann, JA; (2019) Extending the scope of PARP inhibitors in ovarian cancer. [Editorial comment]. The Lancet Oncology , 20 (4) pp. 470-472. 10.1016/S1470-2045(19)30019-1. Green open access
file

Ledermann, JA; Pujade-Lauraine, E; (2019) Olaparib as maintenance treatment for patients with platinum-sensitive relapsed ovarian cancer. Therapeutic Advances in Medical Oncology , 11 pp. 1-18. 10.1177/1758835919849753. Green open access
file

Lee, SM; Upadhyay, S; Lewanski, C; Falk, S; Skailes, G; Woll, PJ; Hatton, M; ... Hackshaw, A; + view all (2019) The clinical role of VeriStrat testing in patients with advanced non-small cell lung cancer considered unfit for first-line platinum-based chemotherapy. European Journal of Cancer , 120 pp. 86-96. 10.1016/j.ejca.2019.07.025. Green open access
file

M

Mato, AR; Roeker, LE; Eyre, TA; Nabhan, C; Lamanna, N; Hill, BT; Brander, DM; ... Fox, CP; + view all (2019) A retrospective comparison of venetoclax alone or in combination with an anti-CD20 monoclonal antibody in R/R CLL. Blood Advances , 3 (10) pp. 1568-1573. 10.1182/bloodadvances.2019000180. Green open access
file

Matulonis, UA; Shapira-Frommer, R; Santin, AD; Lisyanskaya, AS; Pignata, S; Vergote, I; Raspagliesi, F; ... Ledermann, JA; + view all (2019) Antitumor activity and safety of pembrolizumab in patients with advanced recurrent ovarian cancer: results from the phase II KEYNOTE-100 study. Annals of Oncology , 30 (7) pp. 1080-1087. 10.1093/annonc/mdz135. Green open access
file

Matulonis, UA; Walder, L; Nøttrup, TJ; Bessette, P; Mahner, S; Gil-Martin, M; Kalbacher, E; ... Mirza, MR; + view all (2019) Niraparib Maintenance Treatment Improves Time Without Symptoms or Toxicity (TWiST) Versus Routine Surveillance in Recurrent Ovarian Cancer: A TWiST Analysis of the ENGOT-OV16/NOVA Trial. Journal of Clinical Oncology , 37 (34) pp. 3183-3191. 10.1200/JCO.19.00917. Green open access
file

Miller, RE; Crusz, SM; Ledermann, JA; (2019) Olaparib maintenance for first-line treatment of ovarian cancer: will SOLO1 reset the standard of care? Future Oncology , 15 (16) pp. 1845-1853. 10.2217/fon-2019-0057. Green open access
file

N

Newton, C; Murali, K; Ahmad, A; Hockings, H; Graham, R; Liberale, V; Sarker, S-J; ... Lockley, M; + view all (2019) A multicentre retrospective cohort study of ovarian germ cell tumours: Evidence for chemotherapy de-escalation and alignment of paediatric and adult practice. European Journal of Cancer , 113 pp. 19-27. 10.1016/j.ejca.2019.03.001. Green open access
file

O

O'Reilly, MA; Govender, D; Kirkwood, AA; Vora, A; Samarasinghe, S; Khwaja, A; Grandage, V; ... O'Connor, D; + view all (2019) The incidence of invasive fungal infections in children, adolescents and young adults with acute lymphoblastic leukaemia/lymphoma treated with the UKALL2011 protocol: a multicentre retrospective study. [Letter]. British Journal of Haematology , 186 (2) pp. 327-329. 10.1111/bjh.15798. Green open access
file

P

Phillips, EH; Lannon, M; Lopes, A; Chadwick, H; Jones, G; Sieniawski, M; Davies, A; ... Lennard, A; + view all (2019) High-dose chemotherapy and autologous stem cell transplantation in enteropathy-associated and other aggressive T-cell lymphomas: a UK NCRI/Cancer Research UK Phase II Study. [Letter]. Bone Marrow Transplantation , 54 pp. 465-468. 10.1038/s41409-018-0294-2. Green open access
file

R

Rahman, B; Lanceley, A; Kristeleit, R; Ledermann, J; Lockley, M; McCormack, M; Mould, T; (2019) Mainstreamed genetic testing for women with ovarian cancer: first-year experience. Journal of Medical Genetics , 56 (3) pp. 195-198. 10.1136/jmedgenet-2017-105140. Green open access
file

Ray-Coquard, I; Trama, A; Seckl, MJ; Fotopoulou, C; Pautier, P; Pignata, S; Kristensen, G; ... RARECARENet Working Group, .; + view all (2019) Rare ovarian tumours: Epidemiology, treatment challenges in and outside a network setting. European Journal of Surgical Oncology , 45 (1) pp. 67-74. 10.1016/j.ejso.2017.09.025. Green open access
file

Raza, SEA; AbdulJabbar, K; Jamal-Hanjani, M; Veeriah, S; Le Quesne, J; Swanton, C; Yuan, Y; (2019) Deconvolving Convolutional Neural Network for Cell Detection. In: 2019 IEEE 16th International Symposium on Biomedical Imaging (ISBI 2019). (pp. pp. 891-894). IEEE: Venice, Italy,. Green open access
file

Rosenthal, R; Cadieux, EL; Salgado, R; Bakir, MA; Moore, DA; Hiley, CT; Lund, T; ... TRACERx consortium; + view all (2019) Neoantigen-directed immune escape in lung cancer evolution. Nature 10.1038/s41586-019-1032-7. (In press). Green open access
file

Rule, S; Cook, G; Russell, NH; Hunter, A; Robinson, S; Morley, N; Sureda, A; ... Peggs, KS; + view all (2019) Allogeneic stem cell transplantation as part of front line therapy for Mantle cell lymphoma. British Journal of Haematology , 184 (6) pp. 999-1005. 10.1111/bjh.15723. Green open access
file

S

Spiro, SG; Shah, PL; Rintoul, RC; George, J; Janes, S; Callister, M; Novelli, M; ... Hackshaw, A; + view all (2019) Sequential screening for lung cancer in a high-risk group: randomised controlled trial. European Respiratory Journal , 54 (4) , Article 1900581. 10.1183/13993003.00581-2019. Green open access
file

T

Tan, WS; Teo, CH; Chan, D; Heinrich, M; Feber, A; Sarpong, R; Allan, J; ... DETECT II trial collaborators; + view all (2019) Mix methods approach to explore patients' perspectives on the acceptability of a urinary biomarker test in replacement of cystoscopy in bladder cancer surveillance. BJU International , 124 (3) pp. 408-417. 10.1111/bju.14690. Green open access
file

Townsend, W; Leong, S; Hoskin, P; Diez, P; Patrick, P; Linch, D; Wong, W-L; ... Ardeshna, K; + view all (2019) Treatment of classical Hodgkin lymphoma in young adults aged 18-30 years with a modified paediatric Hodgkin lymphoma protocol. Results of a multicentre phase II clinical trial (CRUK/08/012). British Journal of Haematology 10.1111/bjh.16296. (In press). Green open access
file

U

Urkmez, E; Andac-Jones, E; Cibula, D; Querleu, D; Halaska, MJ; Driak, D; Sehouli, J; ... Gultekin, M; + view all (2019) Perceptions, expectations, and experiences of gynecological cancer patients: a pan-European ESGO-ENGAGe survey. International Journal of Gynecological Cancer , 29 (9) pp. 1425-1430. 10.1136/ijgc-2019-000567. Green open access
file

W

Webster, AK; Hung, A; Moore, BT; Guzman, R; Jordan, JM; Kaplan, REW; Hibshman, JD; ... Baugh, LR; + view all (2019) Population Selection and Sequencing of Caenorhabditis elegans Wild Isolates Identifies a Region on Chromosome III Affecting Starvation Resistance. G3 , 9 (10) pp. 3477-3488. 10.1534/g3.119.400617. Green open access
file

Wheeler, G; Pallmann, P; Wan, F; Mander, A; Yap, C; Clive, S; Hampson, L; (2019) Designing and evaluating dose-escalation studies made easy: the MoDEsT web app. Clinical Trials 10.1177/1740774519890146. (In press). Green open access
file

Wheeler, GM; Mander, A; Bedding, A; Brock, K; Cornelius, V; Grieve, A; Jaki, T; ... Bond, S; + view all (2019) How to design a dose-finding study using the Continual Reassessment Method. BMC Medical Research Methodology , 19 , Article 18. 10.1186/s12874-018-0638-z. Green open access
file

Wheeler, GM; Sweeting, M; Mander, A; (2019) A Bayesian model‐free approach to combination therapy phase I trials using censored time‐to‐toxicity data. Journal of the Royal Statistical Society: Series C (Applied Statistics) , 68 (2) pp. 309-329. 10.1111/rssc.12323. Green open access
file

This list was generated on Wed Oct 13 00:57:24 2021 BST.